| Literature DB >> 26435843 |
Kathleen J Sikkema1, Alexis C Dennis2, Melissa H Watt2, Karmel W Choi1, Tatenda T Yemeke2, John A Joska3.
Abstract
People living with HIV (PLWH) experience greater psychological distress than the general population. Evidence from high-incomes countries suggests that psychological interventions for PLWH can improve mental health symptoms, quality of life, and HIV care engagement. However, little is known about the effectiveness of mental health interventions for PLWH in low and middle-income countries (LMICs), where the large majority of PLWH reside. This systematized review aims to synthesize findings from mental health intervention trials with PLWH in LMICs to inform the delivery of mental health services in these settings. A systematic search strategy was undertaken to identify peer-reviewed published papers of intervention trials addressing negative psychological states or disorders (e.g., depression, anxiety) among PLWH in LMIC settings. Search results were assessed against pre-established inclusion and exclusion criteria. Data from papers meeting criteria were extracted for synthesis. Twenty-six papers, published between 2000 and 2014, describing 22 unique interventions were identified. Trials were implemented in sub-Saharan Africa (n=13), Asia (n=7), and the Middle East (n=2), and addressed mental health using a variety of approaches, including cognitive-behavioral (n=18), family-level (n=2), and pharmacological (n=2) treatments. Four randomized controlled trials reported significant intervention effects in mental health outcomes, and eleven preliminary studies demonstrated promising findings. Among the limited mental health intervention trials with PLWH in LMICs, few demonstrated efficacy. Mental health interventions for PLWH in LMICs must be further developed and adapted for resource-limited settings to improve effectiveness.Entities:
Keywords: HIV; intervention; low middle income countries; mental health; review; trials
Year: 2015 PMID: 26435843 PMCID: PMC4589870 DOI: 10.1017/gmh.2015.17
Source DB: PubMed Journal: Glob Ment Health (Camb) ISSN: 2054-4251
Fig. 1.Study selection process.
Randomized controlled trials
| Citation(s) and date of study | Location | Sample | Intervention description | Evaluation design | Outcome measures | Relevant findings |
|---|---|---|---|---|---|---|
| Boivin | Uganda | 119 child-caregiver dyads: caregivers (>90% HIV + mothers) | Name: Mediational intervention for sensitizing caregivers (MISC) | Control: health and nutrition curriculum delivered biweekly over 1 year | ||
| Eller | South Africa, Puerto Rico and US | 222 HIV + adults with self-reported depression during past week | Name: HIV/AIDS symptom management manual | Control: modified WHO HIV/AIDS nutrition manual. Individual received 30-min session on use of manual. | MH outcomes: depressive symptoms (CES-D) | |
| Eloff | Pretoria, South Africa | 390 mother-child pairs | Name: The Kgolo-Mmogo Project Level: group | Control: standard care and information about local resources | ||
| Kaaya | Dar es Salaam, Tanzania | 331 HIV+ pregnant women attending ANC | Name: psychosocial group counseling Level: group | Control: standard of care | MH outcomes: depression (HSCL-25) | |
| Li | Thailand | 507 HIV+ individuals and 308 HIV-negative family members | Name: adaptation of teens and adults learning to communicate (Project TALC, Miller & Rotheram-Borus, | Control: standard of care, including support group for PLWHA and family member | MH outcomes: general mental health (MOS-HIV subscales for health distress and emotional well-being) | |
| Li | Anhui Province, China | 79 families from four villages. All families included at least one HIV+ and one HIV−negative family member. | Name: together for empowerment activities (TEA) | Control: standard of care (educational material and classes on health education, personal hygiene and nutrition) | ||
| Olley ( | Abuja, Nigeria | 67 HIV+ individuals recruited from VCT | Name: psycho-education | Control: 4 weekly 1-h sessions of unstructured individual support | MH outcomes: depression (BDI); | |
| Peltzer | Kwa Zulu Natal, South Africa | 152 HIV+ adults who were new to ARVs and had adherence challenges | Name: medication adherence intervention (MAI) | Control: standard of care: (monthly visit to review health status with medical provider, 20 min) | MH outcomes: depression (BDI-II) | |
| Richter | Kwa Zulu Natal, South Africa | 1200 HIV+ pregnant women on their first antenatal visit; randomized by clinic recruitment site | Name: Masihambisane (‘We Walk Together’) | Control: standard of care (clinical care per the national protocol) | MH outcomes | |
| SeyedAlinaghi | Tehran, Iran | 245 HIV+ adults who had not yet initiated ART | Name: mindfulness-based stress reduction (MBSR) | Control: education and support, including educational information and pamphlets about living with HIV/AIDS | MH outcomes: self-reported mental health (SCL-90R) |
Number of months (m) since baseline; (p) = immediate post assessment.
No significant effect’ or ‘significant effect’ refer to between-condition effects.
Indicates that mental health was a secondary outcome.
No significant difference between conditions; both conditions improved.
NR, not reported; AACTG, Adult AIDS Clinical Trials Group adherence measure; BDI , Beck Depression Inventory; BDI-II, Beck Depression Inventory II; CBCL, Achenbach Child Behavior Checklist; CCBL, Child Behavior Checklist; CCEI, The Crown Crisp Experimental Index; CCNES, Coping with Children's Negative Emotions Scale; CDI, Child Depression Index; CES-D, Center for Epidemiologic Studies-Depression Scale; COAT, Color-Object Association Test; GHQ, General Health Questionnaire; HSCL-25, Hopkins Symptom Checklist; MELS, Mullen Early Learning Scales; MOS-HIV Medical Outcomes Study HIV Health Survey Instrument; MSCL, Medical Symptom Checklist; PBI, Parental Bonding Instrument; RCMAS, Revised Child Manifest Anxiety Scale; RSE, Rosenberg Self-Esteem Scale; SCL-90R, Symptom Checklist-90-Revised; VABS, Vineland Adaptive Behavior Scales.
Pilot and feasibility studies
| Citation(s) and date of study | Sample | Intervention description | Study design | Evaluation design | Outcome measures | Relevant findings | |
|---|---|---|---|---|---|---|---|
| Adams | Northern Zone of Tanzania | 20 HIV+ adults | Intervention: measurement-based care (MBC) to monitor and treat depression | Pre-experimental, one-group pre-post design | Comparison: none | −Depression decreased from baseline to post | |
| Bhana | KwaZulu-Natal, South Africa | 65 families with an HIV+ child aged between 10 and 14 years | Intervention: VUKA family program | Randomized, pre-post, wait list control group pilot design | Control: wait list control ( | ||
| Chan | Hong Kong, China | 16 adult males with symptomatic HIV | Intervention: cognitive-behavioral program (CBP) intervention | Randomized, pre-post, wait list control design | Control: wait list control | −Reductions in depression and distress | |
| Field and Kruger ( | Soshanguve, South Africa | 18 HIV+ women attending an HIV support group | Intervention: art psychotherapy | Experimental, pre-test, post-test and post-post-test design | Comparison: timed matched entertainment workshop. | −Improvements in depression and health locus of control | |
| Jirapaet ( | Bangkok, Thailand | 94 HIV+ mothers | Intervention: empowerment program (EP) | Pre-post, non-equivalent control quasi-experimental design | Comparison: standard of care | −Improvements in coping, quality of life and maternal role adaptation | |
| Molassiotis | Hong Kong, China | 46 adults with symptomatic HIV | Intervention: | Randomized, pre-post pilot trial design | Control: crisis intervention and individual counseling as needed | −Improvements in overall mood states (CBT and PSC) | |
| Mundell | Pretoria, South Africa | 361 HIV+ pregnant women | Intervention: structured psychosocial support group intervention | −Quasi experimental, Pre- post design with convenience comparison group | Comparison: women who declined to join support groups | −No difference between groups for depression or social support | |
| Nyamathi | Andhra Pradesh, India | 68 HIV+ women | Intervention: ASHA-Life | −Pilot prospective study using cluster randomization | Control: usual care: matched sessions in length and time to intervention | −Decrease in depressive symptoms | |
| Pence | Bamenda, Cameroon | 55 HIV+ patients | Intervention: measurement-based Care (MBC) to monitor and treat depression | Pre Experimental, one-group pre-post design | Comparison: none | −87% of participants achieved remission of depression | |
| Petersen | KwaZulu Natal province, South Africa | 76 HIV+ ART clinic patients | Intervention: group-based IPT | Randomized, pre-post, control design | Control: standard of care, including counseling | −Reductions in depression | |
| Ravaei | Terhan, Iran | 30 HIV+ drug using males | Intervention: cognitive behavioral and spiritual training | Pre-post with control group | Control: no treatment | −Improvement in mental health | |
| Yu | Rural China | 75 HIV+ adults, infected via blood/plasma donations | Intervention: intervention to improve resilience, psychosocial well-being, and QOL | Single-arm open evaluative study using a pre-and post-intervention study design | Comparison: none | −Higher resilience, social support, and quality of life |
Indicates that mental health was a secondary outcome.
MH, Mental Health; NR = not reported; AACTG, Adult AIDS Clinical Trial Groups Adherence Measure; BDI-II, Beck Depression Inventory; Brief COPE, abbreviated version of the COPE inventory; CBP, Cognitive Behavioral Program; CBT, Cognitive Behavioral Therapy; CES-D, Center for Epidemiologic Studies Depression Scale; CDI, Child Depression Inventory; CD-RISC, Connor-Davidson Resilience Scale; DASS, Depression, Anxiety, and Stress Scale; HIV-KQ, HIV Knowledge Questionnaire; HSCL-25, Hopkins Symptom Checklist; JCS, Jalowiec Coping Scale; MBC, Measurement Based Care; MCQ, Maternal Caregiving Questionnaire; MHLCS, Multidimensional Health Locus of Control Scale; MOS, Medical Outcomes Study; MOS-HIV, Medical Outcomes Study HIV Health Survey Instrument; MSSI, Multidimensional Social Support Inventory; MSPSS, Multidimensional Scale of Perceived Social Support; MUIS, Mishel Uncertainity in Illness Scale; PACTG, Pediatric AIDS Clinical Trial Groups Adherence Measure; PHQ-9, Patient Health Questionnaire-9; POMS, Profile of Mood States; PSC, Peer support/counseling group therapy; QOL, Quality of Life; RSE, Rosenberg Self-Esteem Scale; SCID-II, Structured Clinical Interview for DSM Disorders; SDQ, Strengths and Difficulties Questionnaire; SF-36, Medical Outcomes Study Short-Form 36; SPQL, Perceived Life Quality Index; SRQ-20, Self-Reporting Questionnaire; TSCS, Tennessee Self-Concept Scale; WHOQOL-BREF-HK, World Health Organization Quality of Life scale.